Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers

INTRODUCTION: TCP-25 gel is intended for use in treatment of wound infection and inflammation. Current local therapies for wounds have limited efficacy to prevent infections and there are no wound treatments available today that target the excessive inflammation that often hampers wound healing in b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundgren, Sigrid, Wallblom, Karl, Fisher, Jane, Erdmann, Susanne, Schmidtchen, Artur, Saleh, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950920/
https://www.ncbi.nlm.nih.gov/pubmed/36813496
http://dx.doi.org/10.1136/bmjopen-2022-064866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950920/
https://www.ncbi.nlm.nih.gov/pubmed/36813496
http://dx.doi.org/10.1136/bmjopen-2022-064866

Ejemplares similares